author-photo

Bo Ma

GlaxoSmithKline

10

Papers

1496

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

2016 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (237)
BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer

2015 Thyroid
Show All
- Source
- Cite
- Save
Citations (115)
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (132)
A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (82)
Interim results of phase II study BRF113928 of dabrafenib in BRAF V600E mutation-positive non-small cell lung cancer (NSCLC) patients.

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (102)
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436).

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (34)
Heterogeneity of FDG-PET response to GSK2118436, an inhibitor of oncogenic mutant BRAF-kinase in BRAF-mutant metastatic melanoma.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)